These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3744171)

  • 1. [Effect of an antihypertensive drug, budralazine, on the cerebral circulation in spontaneously hypertensive rats].
    Tanaka S; Tanaka M; Akashi A
    Nihon Yakurigaku Zasshi; 1986 Jun; 87(6):655-63. PubMed ID: 3744171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of antihypertensive treatment with budralazine on autoregulation of cerebral blood flow in spontaneously hypertensive rats.
    Tanaka S; Tanaka M; Akashi A
    Stroke; 1989 Dec; 20(12):1724-9. PubMed ID: 2595735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of budralazine, a new antihypertensive drug.
    Akashi A; Chiba T; Suzuki I; Hashimoto H
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):134-46. PubMed ID: 736687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre- and postsynaptic alpha-adrenergic effects of the antihypertensive drug budralazine.
    Shibamura S; Chiba T; Suzuki I; Akashi A
    Arzneimittelforschung; 1981; 31(7):1076-9. PubMed ID: 6268123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antihypertensive drugs on experimental cerebral ischemia in spontaneously hypertensive rats.
    Tanaka S; Ashida S; Akashi A
    Jpn J Pharmacol; 1990 Aug; 53(4):502-5. PubMed ID: 2214372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of an antihypertensive drug budralazine on cerebrovascular lesions in salt-loaded SHR].
    Tanaka S; Ishihara M; Shibamura S; Sekiguchi F; Hirohashi M; Shirasaki Y; Akashi A
    Nihon Yakurigaku Zasshi; 1989 Jul; 94(1):49-60. PubMed ID: 2792961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and general pharmacological properties of budralazine.
    Chiba T; Shibamura S; Tanaka M; Yamasaki T; Hashimoto H; Kurebayashi Y; Kasai Y; Ryokawa Y; Tamura K; Hirohashi M; Akashi A
    Arzneimittelforschung; 1981; 31(7):1080-7. PubMed ID: 7023495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the vasodilator action of antihypertensive drug budralazine.
    Chiba T; Hirohashi M; Suzuki I; Tanaka S; Watanabe K; Akashi A
    Arzneimittelforschung; 1983; 33(1):112-6. PubMed ID: 6299307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of 4-methyl-3-penten-2-one (1-phthalazinyl) hydrazone (budralazine) on intra- and extracranial circulation in cats (author's transl)].
    Hagihara Y
    Nihon Yakurigaku Zasshi; 1981 Jan; 77(1):41-50. PubMed ID: 7262706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term antihypertensive treatment on cerebral, thalamic and cerebellar blood flow in spontaneously hypertensive rats (SHR).
    Fujishima M; Ibayashi S; Fujii K; Yao H; Sadoshima S
    Stroke; 1986; 17(5):985-8. PubMed ID: 3764972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of antihypertensive therapy on cerebral autoregulation in aged hypertensive rats.
    Hoffman WE; Miletich DJ; Albrecht RF
    Stroke; 1982; 13(5):701-4. PubMed ID: 7123604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotensive and cardiovascular action of budralazine in unanesthetized and unrestrained dogs.
    Konno K; Nonaka K; Ueno A
    Arzneimittelforschung; 1981; 31(7):1072-5. PubMed ID: 7196755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK; Dubinion JH; Mi Z
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central sympathoinhibitory action of a direct-acting vasodilator, budralazine, in anesthetized rats.
    Yoshioka M; Yahagi H; Minami M; Saito H
    Jpn J Pharmacol; 1987 Jun; 44(2):187-96. PubMed ID: 3656776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of an antihypertensive drug, budralazine, on glucose and lipid metabolism in diabetic SHR].
    Shirasaki Y; Masumura H; Akashi A
    Nihon Yakurigaku Zasshi; 1986 Mar; 87(3):301-11. PubMed ID: 3710313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral blood flow during inhibition of brain nitric oxide synthase activity in normal, hypertensive, and stroke-prone rats.
    Izuta M; Clavier N; Kirsch JR; Traystman RJ
    Stroke; 1995 Jun; 26(6):1079-85. PubMed ID: 7539167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-tachycardiac effect of a direct-acting vasodilator, budralazine].
    Yoshioka M
    Hokkaido Igaku Zasshi; 1989 May; 64(3):255-68. PubMed ID: 2767613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-tachycardic mechanism of a direct-acting vasodilator, budralazine, in rats.
    Yoshioka M; Minami M; Saito H
    Clin Exp Hypertens A; 1991; 13(5):1107-14. PubMed ID: 1773498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of a new vasodilator, budralazine on water drinking activity, plasma norepinephrine, plasma angiotensin II, plasma arginine vasopressin, plasma serotonin concentration, urinary aldosterone excretion rate and urinary catecholamine excretion rate in rats].
    Minami M; Togashi H; Sano M; Saito I; Morii K; Nomura A; Yoshioka M; Saito H
    Hokkaido Igaku Zasshi; 1985 Nov; 60(6):856-64. PubMed ID: 4085968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and vascular activity of LY127210, a new vasodilator, in anesthetized spontaneously hypertensive rats: comparison with hydralazine.
    Steinberg MI; Keller CE; Bemis KG
    Clin Exp Hypertens A; 1985; 7(10):1481-97. PubMed ID: 3841035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.